LBA45 First report of efficacy and safety from the phase II study SECOMBIT (SEquential COMBo Immuno and Targeted therapy study)

Paolo A. Ascierto, Mario Mandalà, Pier Francesco Ferrucci, Piotr Rutkowski, Massimo Guidoboni, A.M. Arance Fernandez, Virginia Ferraresi, Evaristo Maiello, Michele Guida, M. Del Vecchio, M. T. Fierro, Paola Queirolo, Célèste Lebbé, Hildur Helgadóttir, Ignacio Melero, Giuseppe Palmieri, Diana Giannarelli, Antonio Maria Grimaldi, Reinhard Dummer, V. Chiarion Sileni